Vasculitis Syndromes
description
Transcript of Vasculitis Syndromes
![Page 1: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/1.jpg)
Vasculitis Syndromes
Polymyalgia Rheumatica,Giant Cell Arteritis, Wegener’s Granulomatosis,
Polyarteritis Nodosa
![Page 2: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/2.jpg)
What is Vasculitis?
• Disease characterized by inflammation of blood vessel walls, leading to altered blood flow through obstructed walls. This causes ischemia and tissue damage.
• In addition there is an intense inflammatory rxn causing further systemic signs and symptoms
• Can be fatal
![Page 3: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/3.jpg)
You Should Suspect Vasculitis • Unexplained signs and sxs• Multisystem disease• Unexplained elevated ESR/CRP• Skin lesions (palpable purpura)• Ischemic vascular changes (Raynaud’s, gangrene, livedo, claudication)• Glomerulonephritis• Mononeuritis multiplex• Intestinal angina• Inflammatory ocular diease• Arthalgias/arthritis, myalgias• Sudden visual loss/headache
![Page 4: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/4.jpg)
Select Vasculitides
• Polymyalgia Rheumatica
• Giant Cell or Temporal Arteritis
• Wegener’s Granulamatosis
• Polyarteritis Nodosa
![Page 5: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/5.jpg)
Polymyalgia Rheumatica (PMR)
• Most ‘benign‘ of the group• Common: 50/100,000, age > 50, average age
75. Highest prevalence in northern European ancestry, females>>males
• Cause unknown
![Page 6: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/6.jpg)
PMR Clinical Presentation
• Usually abrupt onset• Intense morning stiffness and pain that can last all
day involving the shoulders and hip girdle area• No small joint involvement• Muscle strength normal• Fatigue and anorexia common• Elevated CRP and ESR; anemia of chronic disease,
elevated platelets• 15% get GCA (more later)
![Page 7: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/7.jpg)
PMR Treatment
• Low Dose Steroids (10-20 mg/day)– The only drug that works– Look to normalize the CRP and ESR; if they
continue to be elevated, rethink the dx (?paraneoplastic syndrome or GCA)
– Usually self-limited: 65% of patients able to taper off Prednisone by 1 year, >85% in 2 years
– Disease flares not uncommon as prednisone is tapered and may require dose adjustments
![Page 8: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/8.jpg)
Giant Cell Arteritis
• Can occur exclusively but often seen with PMR• Rare: 15/100,000• Age >50• Cause unknown• Involves the medium/large blood vessels of
the head and neck including the blood vessels that supply the optic nerve
![Page 9: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/9.jpg)
GCA Pathophysiology
• Unknown trigger causes inflammatory response with the release of IL-1 and IL-6.
• This leads to systemic symptoms and the infiltration of inflammatory cells into the adventitia of the temporal and other involved arteries
• Typical histologic pattern: Giant Cells
![Page 10: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/10.jpg)
![Page 11: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/11.jpg)
GCA Clinical Presentation• Variable• Scalp tenderness• Temporal headaches• Jaw Claudication• Sudden loss of vision• +/- PMR sxs• Rare- upper extremity claudication due to subclavian
involvement• Constitutional sxs: FUO, wt loss, fatigue• Bounding OR absent temporal artery pulses• Rarely subclavian bruits
![Page 12: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/12.jpg)
![Page 13: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/13.jpg)
GCA Diagnostic Studies
• Temporal Artery Biopsy is the gold standard• Elevated ESR and CRP, usually levels higher
than in PMR• Anemia • Elevated LFTs not uncommon
![Page 14: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/14.jpg)
Treatment of GCA
• High dose Steroids (60 mg/day) is the only drug that works
• Slow taper over time usually 1-2 years. Some patients require low dose (<10 mg/day) chronically
![Page 15: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/15.jpg)
GCA Complications
• Blindness • Scalp Necrosis• Lingual Infarction• Aortic Dissection/Aneurysm
• Complications from high dose steroids: osteoporosis, cataracts, elevated blood sugars, wt. gain etc.
![Page 16: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/16.jpg)
Wegener’s Granulomatosis (WG)
• Potentially fatal vasculitis involving small vessels
• Rare: 3-14/million, more common in whites, any age but rare in children
• Pathology shows necrotizing granulomas usually in upper airways, lungs and kidneys
![Page 17: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/17.jpg)
WG Pathophysiology
• Complex immunopathogenic events in which the production and activity of ANCAs (usually c-ANCA) play a central role. These autoantibodies interact with primed neutrophils to cause vascular injury and necrosis.
• Histologic lesions show granulomas
![Page 18: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/18.jpg)
WG Clinical Presentation• Variable, multisystem involvement• Organs:
– Eyes: episcleritis/scleritis, proptosis due retro-orbital mass– CNS: rare mass lesion– Upper airway: otitis media, nasal chondritis, sinusitis with purulent
drainage and epistaxis, ulcerations, subglottic stenosis– Kidney: neprotic syndrome, proteinuria, renal failure– Skin: palpable purpura due to leukocytoclastic vasculitis, pyoderma
gangrenosum, panniculitis– Lung: cough, hemoptysis, hemorrhage, resp failure– Cardiac: pericarditis, conduction abnormalities– Systemic: fever, night sweats, wt loss, fatigue
![Page 19: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/19.jpg)
Palpable Purpura
![Page 20: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/20.jpg)
Eye Involvement
![Page 21: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/21.jpg)
Face Involvement
![Page 22: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/22.jpg)
WG Diagnostic Studies
• Presence of c-ANCA (cytoplasmic staining pattern antineutrophil cytoplasmic antibodies + clinical picture is often enough to make the diagnosis. It is + 80-90% of generalized WG.
• If the c-ANCA is -, tissue biopsy of lung or kidney is recommended.
• “Limited” refers to disease limited to the airways; c-ANCA often is -.
![Page 23: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/23.jpg)
Additional labs
• Elevated CRP and ESR• Anemia, leukocytosis, & thrombocytosis• Elevated Cr• Active urine sediment with red cell casts,
hematuria and proteinuria
![Page 24: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/24.jpg)
WG Clinical Course/Progression
• Prior to immunosuppression therapies, WG was uniformly fatal. Now survival rates almost 90% with aggressive treatment.
• High dose steroids and Cyclophosphamide are cornerstone of therapy. Methotrexate or Azathioprine sometimes used as steroid sparing agents.
![Page 25: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/25.jpg)
Polyarteritis Nodosa (PAN)
• Medium vessel vasculitis• Can be caused by Hep B• 5/million cases• Peak incidence 50’s & 60’s, slightly more
common in males
![Page 26: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/26.jpg)
PAN Pathophysiology
• In Hep B assoc cases immune complexes play significant role
• In non Hep B cases, the pathophysiology is less understood
![Page 27: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/27.jpg)
PAN Clinical Presentation
• Systemic: fever, fatigue, wt loss• Abdominal pain due to mesenteric angina/ischemia• Mononeuritis multiplex• Myalgias/arthalgias/mild arthritis• Hypertension• Skin: livedo reticularis, palpable purpura, fingertip
ulceration, subcutaneous nodules• Testicular pain or tenderness
![Page 28: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/28.jpg)
Livedo reticularis
![Page 29: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/29.jpg)
Subcutaneous Nodules
![Page 30: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/30.jpg)
Complications of PAN
• Chronic renal failure• Bowel perforation• Stroke/cerebral hemorrhage due to HTN• Foot/wrist drop
![Page 31: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/31.jpg)
Wrist Drop
![Page 32: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/32.jpg)
Labs of PAN
• Elevation of acute phase reactants (ESR, CRP etc)
• Absence of ANCA• Elevated transaminases, decreased albumin• +/- Hep B• Urine: proteinuria and hematuria without
casts
![Page 33: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/33.jpg)
Imaging Studies of PAN
• Mesenteric and/or renal angiography is the test of choice
• Biopsies seldom done
![Page 34: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/34.jpg)
Angiogram
![Page 35: Vasculitis Syndromes](https://reader035.fdocuments.net/reader035/viewer/2022062323/56816524550346895dd7a91e/html5/thumbnails/35.jpg)
PAN Treatment
• High dose steroids and Cyclophosphamide• Methotrexate or Azathioprine is used as
steroid sparing agents later once the disease is controlled
• Treatment for Hep B with antivirals. Sometimes plasma exchange is used to remove immune complexes